HCFA Joins Private Payers On Electrical Stimulation Coverage Conditions
This article was originally published in The Gray Sheet
Electrical bone growth stimulators will be reimbursed for patients whose fractures demonstrate no radiographic signs of healing over a three-month period, according to a coverage policy revision issued Nov. 9 by the Health Care Financing Administration.
You may also be interested in...
The Health Care Financing Administration is not planning to seek a recommendation on electrical stimulation for fracture healing from its Medicare Coverage Advisory Committee before making a national policy decision, agency staffers report.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.